Eli Lilly

Eli Lilly just delivered fantastic news to investors The Motley Fool04:22
Has Lilly’s obesity drug boom pushed its 2025 Valuation too far? Simply Wall St11:01
New Eli Lilly results suggest major delay to chemotherapy for breast cancer patients Benzinga14:21
Crux Adds Obesity Management Medicine to its Newly Launched Employer Benefit Platform Business Wire (Press Release)08:07
Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama PR Newswire (Press Release)15:32
Moody’s affirms Eli Lilly’s Aa3 rating, outlook revised to positive Investing.com13:16
Lilly's Jaypirca sees 80% risk of disease progression or death in front-line CLL/SLL Phase 3 trial RTT News09:23

Latest News

Yesterday
2 Predictions for Eli Lilly in 2026 The Motley Fool16:04 15-Dec-25
Why Eli Lilly (LLY) Stock Is Trading Up Today Barchart14:25 15-Dec-25
Eli Lilly's Obesity Drug Dominance Still Underpriced By Market, Bank of America Says Benzinga12:17 15-Dec-25
Lilly and Indiana University collaborate to expand clinical trial access PMLiVE06:22 15-Dec-25
Eli Lilly Just Delivered Fantastic News to Investors The Motley Fool04:22 15-Dec-25
In the last 7 days
StockWatch: Positive Obesity Pill Data Has Structure Investors Seeing Double Genetic Engineering and Biotechnology News14:44 14-Dec-25
Eli Lilly’s New Study on LY4213663: A Potential Game-Changer for Rheumatoid Arthritis? TipRanks11:40 14-Dec-25
Eli Lilly’s New Study on LY4584180: A Potential Game-Changer in Blood Cancer Treatment? TipRanks11:40 14-Dec-25
Eli Lilly’s Orforglipron Study: A Potential Game-Changer for PAD Treatment TipRanks11:40 14-Dec-25
Eli Lilly Completes Phase 1 Study of Eloralintide for Obesity in China TipRanks11:40 14-Dec-25
Commentary: The real story behind Trump’s GLP-1 price cut: Markets still rule Las Vegas Review-Journal00:08 14-Dec-25
Has Lilly’s Obesity Drug Boom Pushed Its 2025 Valuation Too Far? Simply Wall St11:01 13-Dec-25
Why the Market Dipped But Eli Lilly (LLY) Gained Today Zacks18:47 12-Dec-25
Ozempic adds to India’s growing appetite for anti-obesity drugs The Financial Express15:54 12-Dec-25
New Eli Lilly Results Suggest Major Delay To Chemotherapy For Breast Cancer Patients Benzinga14:21 12-Dec-25
Moody’s affirms Eli Lilly’s Aa3 rating, outlook revised to positive Investing.com13:16 12-Dec-25
Novo Nordisk bets on cheaper Ozempic to dominate India’s booming weight-loss market The Economic Times12:38 12-Dec-25
Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win Zacks12:30 12-Dec-25
U.S. Regulators Pushed to Fast-Track Approval of Eli Lilly’s Weight-Loss Pill: Reports TipRanks11:09 12-Dec-25
EU committee backs extending use of Lilly’s diabetes drug for children aged 10 and above Investing.com10:37 12-Dec-25
FDA Weighs Rapid Review For Eli Lilly Obesity Pill As Novo Nordisk Nears Launch Benzinga09:05 12-Dec-25
Weight-loss drug developers line up to tap lucrative market as competition heats up BNN Bloomberg08:02 12-Dec-25
Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up Yahoo! US07:33 12-Dec-25
Think Eli Lilly Is Expensive? This Metric Says Otherwise. The Motley Fool07:30 12-Dec-25
SanegeneBio raises $110m for RNAi, plus other financings pharmaphorum04:49 12-Dec-25
Eli Lilly to build $6 B worth API manufacturing facility in US BioSpectrum Asia03:01 12-Dec-25
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments Power Corridor00:05 12-Dec-25
Democratic Senators Demand Details on Trump’s Drugmaker Deals Bloomberg Law15:19 11-Dec-25
Eli Lilly’s latest shot helped patients lose 29% of body weight in trials The Irish Times12:46 11-Dec-25
Eli Lilly (LLY) Stock Is Up, What You Need To Know Barchart12:14 11-Dec-25
Lilly’s Experimental Shot Cuts Body Weight by 23% in Study (2) Bloomberg Law11:55 11-Dec-25
Can Eli Lilly Sustain Its Obesity Momentum as Newer Players Emerge? Zacks11:30 11-Dec-25
Lilly reports solid results from new weight-loss drug trial London South East11:18 11-Dec-25
Eli Lilly reports positive Phase 3 trial results for obesity drug retatrutide Proactive Investors (US)10:26 11-Dec-25
Zepbound Maker Eli Lilly Reports Patients Achieved Dramatic Weight Loss in Study of Newest Obesity Drug The New York Sun10:15 11-Dec-25
Eli Lilly's Next-Gen Experimental Drug Cuts Body Weight By 29%, Helps In Knee Pain Benzinga10:11 11-Dec-25
Eli Lilly's obesity drug trial results, Coca-Cola names next CEO Yahoo! UK & Ireland09:42 11-Dec-25
Eli Lilly's Weight-Loss Drugs Drove Its Stock Higher This Year. A New Plant in Alabama Could Boost Production Investopedia09:40 11-Dec-25
Lilly's obesity triple pulls off 29% weight loss in trial pharmaphorum09:17 11-Dec-25
Lilly Reports Positive Results in Next-Gen Obesity Drug Trial Yahoo! US08:36 11-Dec-25
Crux Adds Obesity Management Medicine to its Newly Launched Employer Benefit Platform Business Wire (Press Release)08:07 11-Dec-25
Eli Lilly stock climbs after retatrutide delivers massive weight loss in trial Investing.com07:07 11-Dec-25
Lilly's next-gen drug tops Zepbound on weight loss in late-stage osteoarthritis trial Yahoo! US07:05 11-Dec-25
STAT Plus: Lilly’s next-gen obesity drug delivers major weight loss in Phase 3 trial, but with… STAT06:53 11-Dec-25
Eli Lilly CEO David Ricks Unveils $6B Alabama Plant to Produce New Obesity Pill IBTimes.co.uk00:23 11-Dec-25
Limestone Co. officials weigh in on infrastructure concerns regarding Eli Lilly coming to Huntsville WAFF19:37 10-Dec-25
Eli Lilly’s $6B Alabama Plant To Create Thousands Of Local Jobs As Pharma Onshoring Expands All Work17:42 10-Dec-25
Major pharmaceutical company to build $6B facility creating over 3,000 jobs MassLive.com16:43 10-Dec-25
Zepbound Is Now Available in Additional Doses at Lower Costs Health Magazine16:06 10-Dec-25
Boehringer Ingelheim and Eli Lilly: Knowledge is Power, Especially When it Comes to Kidney… PR Newswire (Press Release)11:40 10-Dec-25
Abivax stock pops on Eli Lilly takeover speculation Proactive Investors (UK)11:10 10-Dec-25
$6B Commitment: Eli Lilly Expands U.S. Manufacturing With New Huntsville Facility Pharmaceutical Online11:03 10-Dec-25
Eli Lilly (LLY) to Build New $6 Billion Manufacturing Plant in Alabama TipRanks10:24 10-Dec-25
Drug giant Eli Lilly announces major manufacturing facility in Huntsville Alabama Daily News09:25 10-Dec-25
Cipla launches drug for obesity, diabetes The Economic Times09:14 10-Dec-25
Eli Lilly's $6 Billion Alabama Site To Make Next-Gen Weight Loss Pills Benzinga08:24 10-Dec-25
Lilly to establish third new US manufacturing facility in Alabama European Pharmaceutical Review07:57 10-Dec-25
Eli Lilly picks Alabama as home to $6bn orforglipron manufacturing facility Pharmaceutical Technology06:27 10-Dec-25
Thirty-five cases of adverse reactions to Mounjaro reported in first month of availability Korea JoongAng Daily01:21 10-Dec-25
City leaders say Eli Lilly location was hand-picked years ago WAFF00:00 10-Dec-25
'A ripple effect': Kenosha leaders say major companies are transforming county TMJ421:17 9-Dec-25
Economic experts weigh in on Eli Lilly coming to the Rocket City WAFF20:26 9-Dec-25
Governor Ivey Announces Pharmaceutical Giant Lilly Plans $6 Billion Advanced Manufacturing Plant in Huntsville Office of the Governor of Alabama (Press Release)18:09 9-Dec-25
Pharmaceutical giant Eli Lilly announces new manufacturing plant in Huntsville WAFF15:53 9-Dec-25
Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push Yahoo! US15:50 9-Dec-25
Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama PR Newswire (Press Release)15:32 9-Dec-25
Pharmaceutical giant Eli Lilly expected to make “big announcement” during press conference in Huntsville WAFF14:31 9-Dec-25
Nobel Prize-Winning Chemist Carolyn Bertozzi Rejoins Eli Lilly’s (LLY) Board of Directors TipRanks11:49 9-Dec-25
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks10:04 9-Dec-25
Lilly's Jaypirca Sees 80% Risk Of Disease Progression Or Death In Front-Line CLL/Sll Phase 3 Trial RTT News09:23 9-Dec-25
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition PR Newswire (Press Release)08:31 9-Dec-25
Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk TipRanks07:34 9-Dec-25
In the last month
Eli Lilly (LLY) Raises Dividend by 15% TipRanks17:27 8-Dec-25
Lilly declares first-quarter 2026 dividend PR Newswire (Press Release)14:06 8-Dec-25
Eli Lilly's Leukemia Drug Matches Johnson & Johnson's Imbruvica In Untreated Patients Benzinga13:47 8-Dec-25
Carolyn Bertozzi returns to Lilly board of directors PR Newswire (Press Release)10:01 8-Dec-25
Healthcare Relevancies Clashes With Premium Valuations For Direxion's Lly-Focused Elil, Elis ETFs Benzinga08:58 8-Dec-25
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump 24/7 Wall St.08:28 8-Dec-25
Eli Lilly reports Phase III trial results of Jaypirca for CLL/SLL Clinical Trials Arena06:40 8-Dec-25
LLY, PFE: Eli Lilly’s Mounjaro, Pfizer’s Cancer Drug Added to China’s State Insurance List TipRanks02:40 8-Dec-25
Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment Yahoo! US21:52 7-Dec-25
At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma BioPharma Dive14:50 7-Dec-25
Eli Lilly, Pfizer land on China’s first private insurance list The Hindu Business Line00:54 7-Dec-25
Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip? The Motley Fool17:54 6-Dec-25
TheWrap, Eli Lilly and Company Toast Dr. Stacy L. Smith With VIP Beverly Hills Dinner | Photos The Wrap16:01 5-Dec-25
Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by… The Motley Fool12:24 5-Dec-25
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Sanofi Zacks06:51 5-Dec-25
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits … The Motley Fool02:54 5-Dec-25
A deal with Donald Trump is boosting this pharma giant Investors Chronicle02:53 5-Dec-25
IU, Eli Lilly ink partnership for clinical trials WFYI Indianapolis16:21 4-Dec-25
Lilly gets approval for earlier use of Jaypirca in CLL pharmaphorum07:22 4-Dec-25
FDA approves Eli Lilly’s Jaypirca in relapsed or refractory CLL/SLL Pharmaceutical Business Review05:06 4-Dec-25
Lilly and Indiana University to Expand Access to Clinical Trials and Latest Innovative Treatments for Hoosiers Newswise (Press Release)22:12 3-Dec-25
As Eli Lilly Cuts Zepbound Prices, Should You Buy, Sell, or Hold LLY Stock? Barchart14:16 3-Dec-25
1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year The Motley Fool13:38 3-Dec-25
Eli Lilly Stock (LLY) Gets Multiple Price Target Increases as Rally Continues TipRanks11:09 3-Dec-25
Gxp-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of … Business Wire (Press Release)10:46 3-Dec-25
LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website Zacks13:37 2-Dec-25
Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal Investopedia11:18 2-Dec-25
Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple 24/7 Wall St.10:31 2-Dec-25
Forbes Daily: Gen Z Leaders Now Dominate The Forbes 30 Under 30 Forbes08:42 2-Dec-25
Zepbound 30% Price Cut to $299 Still Far Above Cheaper Overseas Options IBTimes.co.uk03:58 2-Dec-25
Eli Lilly cuts Zepbound price by up to 20%: How much the weight loss drug costs now, and where… Mint23:48 1-Dec-25
Zepbound Just Got Cheaper: Lilly Cuts Prices On LillyDirect To Broaden Access Benzinga16:02 1-Dec-25
Eli Lilly cuts price of Zepbound in heightened weight-loss drug competition Proactive Investors (US)11:25 1-Dec-25
Eli Lilly cuts cost of Zepbound vials in weight loss drug price war's latest salvo Quartz10:15 1-Dec-25
Eli Lilly (LLY) Lowers Price of Weight-Loss Drug on Direct-to-Consumer Site TipRanks10:14 1-Dec-25
Eli Lilly slashes obesity drug price by up to 20% Los Angeles Times10:09 1-Dec-25
Eli Lilly Lowers Weight-Loss Drug Zepbound Prices After Trump Deal Forbes09:45 1-Dec-25
Eli Lilly cuts Zepbound price to widen access for obesity drug Yahoo! US08:09 1-Dec-25
Real-world trial of Lilly's tirzepatide starts in UK pharmaphorum07:38 1-Dec-25
Eli Lilly (LLY): Evaluating Valuation as Mounjaro and Zepbound Fuel Growth and Policy Expands Access Simply Wall St01:12 1-Dec-25
Eli Lilly, Strategy, Applied Materials, Rocket Lab, and QuantumScape: Insider Moves Unveiled TipRanks08:09 29-Nov-25
Why Eli Lilly's 'market-cap explosion' might be 'misplaced' Yahoo! UK & Ireland16:06 28-Nov-25
S&P 500 Gains and Losses Today: Intel Soars Amid Apple Deal Rumors; Eli Lilly Stock Slides Yahoo! US14:57 28-Nov-25

      
            
      
    view more headlines
   
      
      
      
15 Dec 16:04
   

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

Eli Lilly

Latest News

About our Eli Lilly news

Pharmaceuticals Top Stories

Business Top Stories